Preoperative Differentiation of HER2‐Zero and HER2‐Low from HER2‐Positive Invasive Ductal Breast Cancers Using BI‐RADS MRI Features and Machine Learning Modeling
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.29447
Abstract: Accurate determination of human epidermal growth factor receptor 2 (HER2) is important for choosing optimal HER2 targeting treatment strategies. HER2‐low is currently considered HER2‐negative, but patients may be eligible to receive new anti‐HER2 drug conjugates. read more here.
Keywords: zero her2; her2 low; her2; differentiation her2 ... See more keywords